NAVIGATION

July 24, 2017
Prevacus

Photo:

Jacob VanLandingham

Profile

Prevacus

| 2/22/2013

Neuroscientist Jacob VanLandingham, an assistant professor at Florida State University's college of medicine, began research in 2004 to develop a drug to treat concussions. "We recognized within the last few years between military and sports injuries, that concussions have become an epidemic, so we made an effort to find something for this population." The result: VanLandingham recently patented a neurosteroid drug and launched a company, Prevacus, at Tallahassee’s Innovation Park, for work on funding, preclinical trials and product refinement. The development has sparked interest from the Department of Defense and from the University of Pittsburgh Medical Center, a professional sports affiliate that has agreed to help with clinical trials, which could begin within the next 18 to 36 months.

Tags: Trendsetters, Healthcare, Research & Development

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

The grande dame of Homestead just retired — at 97
The grande dame of Homestead just retired — at 97

Ruth Campbell retired last month as director of Homestead’s Historic Town Hall Museum . . . at the age of 97. She was known as the grande dame of Homestead after serving the city for more than seven decades. 

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Are you concerned proposed changes to federal civil forfeiture policy could be used by agencies to sidestep Florida's asset seizure laws?

  • Yes, quite bothered.
  • Eh... probably not a big deal...
  • No, not worried at all.
  • Wait... Who said what?

See Results

Ballot Box
Subscribe